Futura Medical Reports Maiden Profit and Outlook

2 min read | September 10, 2024 03:43 AM PDT | By Team Kalkine Media

Google News:

Futura Medical Reports Maiden Profit and Outlook — Image source: Shutterstock

Recent News

Why AbbVie (NYSE:ABBV) Gains in S&P 500 Index Biopharma Push?

Why FactSet Research Systems Anchors Index Stability Gains Now?

Why Is M&T Bank Driving S&P 500 Index Regional Banking Strength?

Why Is MPLX Expanding Midstream Across NYSE Composite Energy?

Make Kalkine Media
My Trusted Source

Futura Medical PLC, a player in the healthcare sector, has announced a notable achievement with its first-ever profit. For the first half of 2024, the company reported a profit of £1 million on revenue of £7 million. The company concluded this period with £3.9 million in cash on its balance sheet.

Positive Outlook for 2024

Futura Medical Plc (OTC:FAMDF) has provided a positive forecast for the full year, indicating that both revenue and profit are expected to "significantly exceed" market expectations. This announcement follows the initial pilot launch of the company’s erectile dysfunction gel, Eroxon, which has been met with favorable reception.

Product Launch and Expansion

The company is preparing for the US launch of Eroxon, a fast-acting gel designed to help users achieve an erection within ten minutes. Eroxon, which is being launched in partnership with healthcare giant Haleon, is already available for pre-order online and is expected to be in stores in the US from October.

The upcoming US launch triggers a milestone payment for Futura Medical, similar in scale to the previous one. Eroxon has already been successfully introduced in over ten countries, including key European markets such as France, Italy, and Spain, with additional launches planned for 2024.

Enhanced Production and Licensing

To support the growing demand for Eroxon, Futura Medical has engaged two new contract manufacturers to enhance its supply chain and production capacity. Additionally, the company has extended its licensing agreement with Cooper until 2029, ensuring continued market access and stability

Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media LLC (Kalkine Media, we or us) and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures/music displayed/used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source (public domain/CC0 status) to where it was found and indicated it, as necessary.